{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T15:36:57Z","timestamp":1770824217353,"version":"3.50.1"},"reference-count":33,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2006,12,1]],"date-time":"2006-12-01T00:00:00Z","timestamp":1164931200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2006,12]]},"DOI":"10.1016\/j.humpath.2006.06.009","type":"journal-article","created":{"date-parts":[[2006,9,26]],"date-time":"2006-09-26T12:02:59Z","timestamp":1159272179000},"page":"1601-1606","source":"Crossref","is-referenced-by-count":41,"title":["Expression of \u03b1-methylacyl\u2013coenzyme A racemase in dysplastic Barrett's epithelium"],"prefix":"10.1016","volume":"37","author":[{"given":"Mikhail","family":"Lisovsky","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olga","family":"Falkowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tawfiqul","family":"Bhuiya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2006.06.009_bib1","series-title":"Surgical pathology of the GI tract, liver, biliary tract, and pancreas","first-page":"121","article-title":"Inflammatory disorders of the esophagus","author":"Bronner","year":"2004"},{"key":"10.1016\/j.humpath.2006.06.009_bib2","first-page":"12","article-title":"Dysplasia arising in Barrett's esophagus: diagnostic pitfalls and natural history","volume":"19","author":"Goldblum","year":"2002","journal-title":"Semin Diagn Pathol"},{"key":"10.1016\/j.humpath.2006.06.009_bib3","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1111\/j.1572-0241.1998.00362.x","article-title":"Practice guidelines on the diagnosis, surveillance, and therapy of Barrett's esophagus. The practice parameters committee of the American College of Gastroenterology","volume":"93","author":"Sampliner","year":"1998","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.humpath.2006.06.009_bib4","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/S0046-8177(88)80344-7","article-title":"Observer variation in the diagnosis of dysplasia in Barrett's esophagus","volume":"19","author":"Reid","year":"1988","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2006.06.009_bib5","first-page":"1669","article-title":"Predictors of progression to cancer in Barrett's esophagus: baseline histology and flow cytometry identify low- and high-risk patient subsets","volume":"95","author":"Reid","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.humpath.2006.06.009_bib6","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1053\/gast.2001.25111","article-title":"Extent of high-grade dysplasia in Barrett's esophagus correlates with risk of adenocarcinoma","volume":"120","author":"Buttar","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.humpath.2006.06.009_bib7","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S1055-3207(02)00002-9","article-title":"Epidemiologic trends in esophageal and gastric cancer in the United States","volume":"11","author":"Brown","year":"2002","journal-title":"Surg Oncol Clin N Am"},{"key":"10.1016\/j.humpath.2006.06.009_bib8","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1111\/j.1572-0241.2005.41201.x","article-title":"Dysplasia in Barrett's esophagus: limitations of current management strategies","volume":"100","author":"Spechler","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.humpath.2006.06.009_bib9","first-page":"466","article-title":"Diagnosis and therapy of early neoplasia in Barrett's esophagus","volume":"21","author":"Bergman","year":"2005","journal-title":"Curr Opin Gastroenterol"},{"key":"10.1016\/j.humpath.2006.06.009_bib10","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1042\/bst0290250","article-title":"Peroxisomal fatty acid alpha- and beta-oxidation in humans: enzymology, peroxisomal metabolite transporters and peroxisomal diseases","volume":"29","author":"Wanders","year":"2001","journal-title":"Biochem Soc Trans"},{"key":"10.1016\/j.humpath.2006.06.009_bib11","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/j.1432-1033.1994.tb18870.x","article-title":"Purification and properties of an alpha-methylacyl-CoA racemase from rat liver","volume":"222","author":"Schmitz","year":"1994","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.humpath.2006.06.009_bib12","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/S0046-8177(03)00268-5","article-title":"Expression of alpha-methylacyl-CoA racemase (P504s) in various malignant neoplasms and normal tissues: a study of 761 cases","volume":"34","author":"Jiang","year":"2003","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2006.06.009_bib13","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1158\/1055-9965.EPI-04-0607","article-title":"Alpha-methylacyl-CoA racemase protein expression is associated with the degree of differentiation in breast cancer using quantitative image analysis","volume":"14","author":"Witkiewicz","year":"2005","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"10.1016\/j.humpath.2006.06.009_bib14","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1097\/01.pas.0000167364.90899.59","article-title":"Differential expression of alpha-methylacyl coenzyme a racemase in adenocarcinomas of the small and large intestines","volume":"29","author":"Chen","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2006.06.009_bib15","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.cdp.2003.07.003","article-title":"A dietary enzyme: alpha-methylacyl-CoA racemase\/P504S is overexpressed in colon carcinoma","volume":"27","author":"Jiang","year":"2003","journal-title":"Cancer Detect Prev"},{"key":"10.1016\/j.humpath.2006.06.009_bib16","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1097\/00000478-200111000-00007","article-title":"P504S: a new molecular marker for the detection of prostate carcinoma","volume":"25","author":"Jiang","year":"2001","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2006.06.009_bib17","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1097\/00000478-200207000-00012","article-title":"Alpha-methylacyl-CoA racemase: a novel tumor marker over-expressed in several human cancers and their precursor lesions","volume":"26","author":"Zhou","year":"2002","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2006.06.009_bib18","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.humpath.2004.03.019","article-title":"Analysis of alpha-methylacyl-CoA racemase (P504S) expression in high-grade prostatic intraepithelial neoplasia","volume":"35","author":"Wu","year":"2004","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2006.06.009_bib19","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/S0002-9440(10)63167-7","article-title":"Elevated alpha-methylacyl-CoA racemase enzymatic activity in prostate cancer","volume":"164","author":"Kumar-Sinha","year":"2004","journal-title":"Am J Pathol"},{"key":"10.1016\/j.humpath.2006.06.009_bib20","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1309\/EJUYUQPEX1MG68MK","article-title":"Discovery and clinical application of a novel prostate cancer marker: alpha-methylacyl CoA racemase (P504S)","volume":"122","author":"Jiang","year":"2004","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.humpath.2006.06.009_bib21","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1053\/hupa.2001.23511","article-title":"Dysplasia as a predictive marker for invasive carcinoma in Barrett esophagus: a follow-up study based on 138 cases from a diagnostic variability study","volume":"32","author":"Montgomery","year":"2001","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2006.06.009_bib22","doi-asserted-by":"crossref","first-page":"438","DOI":"10.4065\/76.4.438","article-title":"Biomarkers in Barrett esophagus","volume":"76","author":"Krishnadath","year":"2001","journal-title":"Mayo Clin Proc"},{"issue":"Suppl 1","key":"10.1016\/j.humpath.2006.06.009_bib23","first-page":"102A","article-title":"Immunostaining for AMACR is useful in distinguishing reactive from dysplastic epithelium in Barrett's esophagus and inflammatory bowel disease","volume":"18","author":"Dorer","year":"2005","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2006.06.009_bib24","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S1052-5157(03)00006-0","article-title":"Biomarkers in Barrett's esophagus","volume":"13","author":"Reid","year":"2003","journal-title":"Gastrointest Endosc Clin N Am"},{"key":"10.1016\/j.humpath.2006.06.009_bib25","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1016\/0016-5085(93)91058-P","article-title":"p53 protein accumulation in Barrett's metaplasia, dysplasia, and carcinoma: a follow-up study","volume":"105","author":"Younes","year":"1993","journal-title":"Gastroenterology"},{"key":"10.1016\/j.humpath.2006.06.009_bib26","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/0003-4975(94)90551-7","article-title":"Potential application of p53 as an intermediate biomarker in Barrett's esophagus","volume":"57","author":"Jones","year":"1994","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.humpath.2006.06.009_bib27","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/path.1711750204","article-title":"Accumulation of p53 protein in normal, dysplastic, and neoplastic Barrett's oesophagus","volume":"175","author":"Krishnadath","year":"1995","journal-title":"J Pathol"},{"key":"10.1016\/j.humpath.2006.06.009_bib28","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/0016-5085(94)90225-9","article-title":"TP53 gene mutations and p53 protein immunoreactivity in malignant and premalignant Barrett's esophagus","volume":"107","author":"Hamelin","year":"1994","journal-title":"Gastroenterology"},{"key":"10.1016\/j.humpath.2006.06.009_bib29","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1002\/(SICI)1097-0142(19970201)79:3<425::AID-CNCR1>3.0.CO;2-H","article-title":"p53 protein accumulation and p53 gene mutation in esophageal carcinoma. A molecular and immunohistochemical study with clinicopathologic correlations","volume":"79","author":"Coggi","year":"1997","journal-title":"Cancer"},{"key":"10.1016\/j.humpath.2006.06.009_bib30","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1093\/jnci\/92.16.1316","article-title":"Prospective study of cyclin D1 overexpression in Barrett's esophagus: association with increased risk of adenocarcinoma","volume":"92","author":"Bani-Hani","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.humpath.2006.06.009_bib31","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1111\/j.1572-0241.2001.04236.x","article-title":"Predictors of progression in Barrett's esophagus II: baseline 17p (p53) loss of heterozygosity identifies a patient subset at increased risk for neoplastic progression","volume":"96","author":"Reid","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.humpath.2006.06.009_bib32","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.1111\/j.1572-0241.2001.05261.x","article-title":"Predictors of progression in Barrett's esophagus III: baseline flow cytometric variables","volume":"96","author":"Rabinovitch","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.humpath.2006.06.009_bib33","first-page":"1669","article-title":"Predictors of progression to cancer in Barrett's esophagus: baseline histology and flow cytometry identify low- and high-risk patient subsets","volume":"95","author":"Reid","year":"2000","journal-title":"Am J Gastroenterol"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817706003789?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817706003789?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,13]],"date-time":"2019-01-13T00:00:05Z","timestamp":1547337605000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817706003789"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,12]]},"references-count":33,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2006,12]]}},"alternative-id":["S0046817706003789"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2006.06.009","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2006,12]]}}}